Mild cognitive impairment (MCI): Characteristics, risk factors and prevention

Harefuah

Volumn 145, Issue 3 SPEC. ISS., 2006, Pages 229-234

  Halperin, Ilan ^a   Korczyn, Amos D ^b  

^a Sourasky Medical Center Department of Neurololgy Memory Clinic

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aging brain; Alzheimer's disease (AD); Dementia; Memory; Mild cognitive impairment (MCI)

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; COGNITIVE DEFECT; HUMAN; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

AGED; AGING; ALZHEIMER DISEASE; COGNITION DISORDERS; HUMANS; RISK FACTORS;

EID: 33646114527     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Bartzokis G, Beckson M, Lu PH & al, Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry, 2001; 58: 461-465.
2. Robels A, Del Ser T, Alom J & al, Proposal of criteria for clinical diagnosis of mild cognitive impairment, dementia and Alzheimer's disease. Neurologia, 2002; 17: 17-32.
3. Burns A & Zaudig M, Mild cognitive impairment in older people. Lancet, 2002; 360: 1963-1965.
4. Hultsch DF, MacDonald SW, Hunter MA & al, Intraindividual variability in cognitive performance in older adults: comparison of adults with mild dementia, adults with arthritis, and healthy adults. Neuropsychology, 2000; 14: 588-598.
5. Leon J, Cheng CK & Neumann P, Alzheimer's disease care: costs and potential savings. Health Affairs, 1998; 17: 206-216.
6. Lopez OL, Jagust WJ, DeKosky SY & al, Prevalence and classification of mild cognitive impairment in the cardiovascular health study cognition study. Arch Neurol, 2003; 60: 1385-1389.
7. Grundman M, Petersen RC, Morris JC & al, ADSC Cooperative Study. Rate of dementia of the Alzheimer type (DAT) in subjects with mild cognitive impairment. Neurology, 1996; 46: A 403.
8. Hanninen T, Hallikainen M, Tuomainen S & al, Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand, 2002; 106: 148-154.
9. Crook TH, Bartus RT, Ferris SH & al, Age associated memory impairment: proposed diagnostic criteria measures of clinical change - report of a National Institute of Mental Health Work Group. Dev Neuropsychol, 1986; 2: 261-276.
10. Bischkopf J, Busse A & Angermeyer MC, Mild cognitive impairment - a review of prevalence, incidence and outcome according to current approaches. Acta Psychiatr Scand, 2002; 106: 403-414.
11. Jacobs DM, Sano M, Dooneief G & al, Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology, 1995; 45: 957-962.
12. Chertkow H, Mild cognitive impairment. Curr Opin Neurol, 2002; 15: 401-407.
13. Smith G, Ivnik RJ, Petersen RC & al, Age associated memory impairment diagnosis: problems of reliability and concerns of terminology. Psychol Aging, 1991; 6: 551-558.
14. Honninen T, Hallikainen M, Koivisto K & al, A follow-up study of age-associated memory impairment: Neuropsychological predictors of dementia. J Am Geriatr Soc, 1995; 43: 1007-1015.
15. Amieva H, Letenneur L, Dartigues JF & al, Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study. Dement Geriatr Cogn Disord, 2004; 18: 87-93.
16. Brayne C, Best N, Muir M & al, Five-year incidence and prediction of dementia and cognitive decline in a population sample of omen aged 70-79 at baseline. Int J Geriatr Psychiatr, 1997; 12: 1107-1118.
17. Hogan E, Predicting who will develop dementia in a cohort of Canadian seniors. Can J Neurol Sci, 2000; 27: 18-24.
18. O'Brien MD & Levi R, Age associated memory impairment. BMJ, 1992; 304: 5-6.
19. Cabeza R, Functional neuroimaging of cognitive aging. In: Cabeza R & Kingstone A (Ed.) Handbook of Functional Neuroimaging of Cognition, USA, MIT Press, 2001, pp 331-377.
20. Killiany RJ, Gomez-Isla T, Moss M & al, Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol, 2000; 47: 430-439.
21. Dickerson BC, Salt DH, Bates JF & al, Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol, 2004; 56: 27-35.
22. Gomez-Isla T, Hollister R, West H & al, Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol, 1997; 41: 17-24.
23. Hyman BT, Van Hoesene GW, Krtoner C & al, Alzheimer's disease: cell specific pathology isolates the hippocampal formation. Science, 1984; 225: 1168-1170.
24. De Santi S, de Leon MJ, Rusinek H & al, Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging, 2001; 22: 529-539.
25. Capizzano AA, Acion L, Bekinschtein T & al, White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease. J Neurol Neurosurg Psychia, 2004; 75: 822-827.
26. De Groot JC, de Leeuw FE, Oudkerk M & al, Cerebral white matter lesions and cognitive function: The Rotterdam Scan study. Ann Neurol, 2000; 47: 145-151.
27. Price J, Co A, Wade M & al, Neuron numbers in the endothelial cortex and CA1 in pre-clinical Alzheimer's disease. Arch Neurol, 2001; 58: 1395-1402.
28. Bouras C, Evolution of AD pathology in the aging brain. Geneva, Switzerland: Am Acad Neurol, 2002.
29. Smith G, Is mild cognitive impairment bridging the gap between normal aging and Alzheimer's disease? J Neural Transm Suppl, 2002; 62: 97-104.
30. Solfrzzi V, Panza F, Torres F & al, A Selective attention skills in differentiating between Alzheimer's disease and normal aging. J Ger Psych Neurol, 2002; 15: 99-109.
31. Feldman H, Levy AR, Hsiung GY & al, A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neurology, 2003; 22: 265-274.
32. Treves TA, Bornstein NM, ChapmamJ & al, APOE-epsilpn 4 in patients with Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord, 1996; 10: 189-191.
33. Small BJ, Basun H & Backman L, Three-year changes in cognitive performance as a function of apolipoprotein E genotype: evidence from very old adults without dementia. Psychol Aging, 1998; 13: 80-87.
34. Thal LJ, Therapeutics and mild cognitive impairment: current status and future directions. Alzheimer Dis Assoc Disord, 2003; 17 Suppl 2: S69-S71.
35. Attain H, Bentue-Ferrer D & Akwa Y, Mild cognitive impairment' a treatment at last? Lancet Neurol, 2004; 3: 643.
36. Kurz A, Diehl J, Riemenschneider M & al, Mild cognitive disorder. Questions of definition, diagnosis, prognosis and therapy. Nervenarat, 2004; 75: 6-15.
37. Tan RS, Pu SJ & Culberson JW, Role of androgens in mild cognitive impairment and possible interventions during andropause. Med Hypotheses, 2003; 60: 448-52.
38. De Carli, Mild cognitive impairment: prevalence, prognosis, etiology, and treatment. Lancet Neurol, 2003; 2: 15-21.
39. Abbott RD, White LR, Ross GW & al, Height as a marker of childhood development and late-life cognitive function: The Honolulu-Asia aging study. Pediatrics, 1998; 102: 602-609.
40. Verghese J, Lipton BL, Katz MJ & al, Leisure activities and the risk of dementia in the elderly. New England J Med, 2003; 348: 2508-2516.